Cargando…
SLC25A21 Suppresses Cell Growth in Bladder Cancer via an Oxidative Stress-Mediated Mechanism
BACKGROUND: Bladder cancer (BCa) is a commonly diagnosed malignancy worldwide that has poor survival depending on its intrinsic biologic aggressiveness and a peculiar radio- and chemoresistance features. Gaining a better understanding of tumorigenesis and developing new diagnosis and treatment strat...
Autores principales: | Wang, Yong, Gao, Jiawen, Hu, Shasha, Zeng, Weiting, Yang, Hongjun, Chen, Hui, Wang, Shuang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8458862/ https://www.ncbi.nlm.nih.gov/pubmed/34568013 http://dx.doi.org/10.3389/fonc.2021.682710 |
Ejemplares similares
-
SLC25A25-AS1 over-expression could be predicted the dismal prognosis and was related to the immune microenvironment in prostate cancer
por: Zhao, Ying-Ying, et al.
Publicado: (2022) -
Down-regulation of SLC25A20 promotes hepatocellular carcinoma growth and metastasis through suppression of fatty-acid oxidation
por: Yuan, Peng, et al.
Publicado: (2021) -
Overexpression of lncRNA SLC16A1-AS1 Suppresses the Growth and Metastasis of Breast Cancer via the miR-552-5p/WIF1 Signaling Pathway
por: Jiang, Bin, et al.
Publicado: (2022) -
Pevonedistat Suppresses Pancreatic Cancer Growth via Inactivation of the Neddylation Pathway
por: Xu, Junfeng, et al.
Publicado: (2022) -
Development of a 21-miRNA Signature Associated With the Prognosis of Patients With Bladder Cancer
por: Yin, Xiao-Hong, et al.
Publicado: (2019)